APOLLON

Apollon Formularies is a London, England and Jamaican based publicly traded (AQUS:APOL), international medical cannabis pharmaceutical company specialising in cutting edge research and treatment of patients with cancer and chronic pain. Apollon is federally legal, licensed by the Cannabis Licensing Authority (CLA) in Jamaica, holds a suite of CLA licences which allow the company to work with full spectrum oils inclusive of high levels of THC. Apollon medical cannabis formulations are currently available by prescription to any licensed Jamaican doctor for their patients and for export via licensed partners to any jurisdiction allowing legal import.

Also known as: Apollon Formularies, Apollon Formularies Jamaica Ltd, Apollon Formularies PLC, Apollon International

Primary location: United Kingdom